Please Wait
Applying Filters...
menu
    • menu
    Fermion-PSE
    News
    Fermion Expands API Capacity with Hanko Site Renovation

    07 Aug 2025

    // PRESS RELEASE

    Crystallization as a Core Competence in API Manufacturing

    17 Jun 2025

    // PRESS RELEASE

    New Micronization Equipment at Fermion Oulu plant

    23 Apr 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Fermion VB

    Contact Supplier

    Website

    CPhI North America

    Booth #1629

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/fermion-oy/partner-in-generic-apis-cdmo-services
    Menu

    Fermion Oy

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 14-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    02 29,10-Dehydro Folitixorin Chloride

    03 1N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide

    04 1N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    05 1N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    06 1methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

    07 1methyl 2-amino-3-hydroxypropanoate hydrochloride

    08 1±2-amino-3-hydroxypropanehydrazide hydrochloride

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    89365-50-4
    Salmeterol Xinafoate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    01

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    CAS Number : 89365-50-4

    End Use API : Salmeterol Xinafoate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Levoleucovorin Calcium
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    02

    9,10-Dehydro Folitixorin Chloride

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Levoleucovorin Calcium

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Calcium Folinate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    03

    9,10-Dehydro Folitixorin Chloride

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Calcium Folinate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-c...

    Intermediate Web Link

    Market Place

    1168152-07-5
    Nintedanib Esylate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    04

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-c...

    CAS Number : 1168152-07-5

    End Use API : Nintedanib Esylate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    Intermediate Web Link

    Market Place

    5619-04-5
    Benserazide Hydrochloride
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    05

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    methyl 2-amino-3-hydroxypropanoate hydrochloride

    CAS Number : 5619-04-5

    End Use API : Benserazide Hydrochloride

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)pro...

    Intermediate Web Link

    Market Place

    73573-87-2
    Formoterol Fumarate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    06

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)pro...

    CAS Number : 73573-87-2

    End Use API : Formoterol Fumarate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    Intermediate Web Link

    Market Place

    262368-30-9
    Nintedanib Esylate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    07

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    CAS Number : 262368-30-9

    End Use API : Nintedanib Esylate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    Intermediate Web Link

    Market Place

    163923-18-0
    Salmeterol Xinafoate
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    08

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    CAS Number : 163923-18-0

    End Use API : Salmeterol Xinafoate

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    Intermediate Web Link

    Market Place

    55819-71-1
    Benserazide Hydrochloride
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fu...
    Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    fermion

    09

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    Finland
    CPhI North America
    Booth #1629
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    ±2-amino-3-hydroxypropanehydrazide hydrochloride

    CAS Number : 55819-71-1

    End Use API : Benserazide Hydrochloride

    About the Company : Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO ...

    fermion

    Intermediate Web Link

    Market Place

    Contact Fermion Oy and get a quotation

    Fermion Oy is a supplier offers 28 products (APIs, Excipients or Intermediates).

    Find Alprazolam bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Azathioprine bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Formoterol Fumarate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Hydroxychloroquine Sulphate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Irinotecan Hydrochloride bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Mercaptopurine bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Methotrexate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Sodium Cromoglicate bulk with DMF, CEP, JDMF offered by Fermion Oy

    Find Buspirone Hydrochloride bulk with DMF, CEP offered by Fermion Oy

    Find Carbidopa bulk with DMF, CEP offered by Fermion Oy

    Find Dexmedetomidine Hydrochloride bulk with DMF, JDMF offered by Fermion Oy

    Find Entacapone bulk with DMF, CEP offered by Fermion Oy

    Find Nadolol bulk with DMF, JDMF offered by Fermion Oy

    Find Quetiapine Hemifumarate bulk with DMF, CEP offered by Fermion Oy

    Find Toremifene Citrate bulk with DMF, JDMF offered by Fermion Oy

    Find Benserazide Hydrochloride bulk with CEP offered by Fermion Oy

    Find Budesonide bulk with CEP offered by Fermion Oy

    Find Carbidopa bulk with CEP offered by Fermion Oy

    Find Diltiazem Hydrochloride bulk with DMF offered by Fermion Oy

    Find Levosimendan bulk with DMF offered by Fermion Oy

    Find Methotrexate bulk with DMF offered by Fermion Oy

    Find Nintedanib Esylate bulk with DMF offered by Fermion Oy

    Find Quetiapine Hemifumarate bulk with DMF offered by Fermion Oy

    Find Tolnaftate bulk with DMF offered by Fermion Oy

    Find Dabrafenib Mesylate bulk offered by Fermion Oy

    Find Detomidine bulk offered by Fermion Oy

    Find Dexmedetomidine Hydrochloride bulk offered by Fermion Oy

    Find Lisdexamfetamine Dimesylate bulk offered by Fermion Oy

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.